2016
DOI: 10.1039/c6cc01749e
|View full text |Cite
|
Sign up to set email alerts
|

Whole-cell microtiter plate screening assay for terminal hydroxylation of fatty acids by P450s

Abstract: A readily available galactose oxidase (GOase) variant was used to develop a whole cell screening assay. This endpoint detection system was applied in a proof-of-concept approach by screening a focussed mutant library. This led to the discovery of the thus far most active P450 Marinobacter aquaeolei mutant catalysing the terminal hydroxylation of fatty acids.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 31 publications
0
15
0
Order By: Relevance
“…The measured biocatalytic performance expressed in terms of the total turnover numbers (TTN), that is, the ratio between total product concentration and catalyst concentration, calculated over 24 h is shown in Figure . Here, the variability of P450 expression in E. coli may lead to misjudging the observed yields, thus, a fast, whole‐cell assay was implemented to determine P450 concentration, which was then used to normalize enzyme activity . Finally, the enantiomeric excess values ( ee ) were also determined by comparison with synthesised standards.…”
Section: Resultsmentioning
confidence: 84%
“…The measured biocatalytic performance expressed in terms of the total turnover numbers (TTN), that is, the ratio between total product concentration and catalyst concentration, calculated over 24 h is shown in Figure . Here, the variability of P450 expression in E. coli may lead to misjudging the observed yields, thus, a fast, whole‐cell assay was implemented to determine P450 concentration, which was then used to normalize enzyme activity . Finally, the enantiomeric excess values ( ee ) were also determined by comparison with synthesised standards.…”
Section: Resultsmentioning
confidence: 84%
“…We started this investigation of a cofactor‐free P450 BM3 system by focusing on an electrochemically active molecule for direct on‐electrode enzyme activity detection. Previous work with P450 assay systems showed that para ‐aminophenol is both electrochemically active and a product of P450‐catalysed aniline hydroxylation .…”
Section: Resultsmentioning
confidence: 99%
“…Some wild-type organisms have found applications in drug synthesis. 9 The solubility and ease of high level heterologous production of bacterial CYPs in Escherichia coli make them attractive for developing new biotechnological applications in, for example, the synthesis of fine chemicals, [10][11][12][13][14][15][16][17][18][19] intermediates, 14, [20][21][22] drugs, [23][24][25][26][27][28] and antibiotics. [29][30][31] However, many of the Class I CYP enzymes are not genetically associated with their Fdx.…”
Section: Introductionmentioning
confidence: 99%